https://www.ajmc.com/view/intravitreal-faricimab-associated-with-increased-treatment-interval-decreased-cst
Although intravitreal faricimab helped to decrease central subfield thickness (CST) in patients with eyes previously treated for neovascular age-related...
intravitrealfaricimabassociatedincreasedtreatment